Tokyo, April 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061357) titled 'A prospective observational study to explore the efficacy of oral zinc supplementation in patients with anticancer drug-associated skin disorders' on April 22.
Study Type:
Observational
Primary Sponsor:
Institute - University of Fukui
Condition:
Condition - Urological malignancies
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To investigates whether oral zinc supplementation reduces the incidence of drug-induced skin complications in patients newly initiated with molecularly targeted drugs, immune checkpoint inhibitors, androgen receptor inhibitors, or anti...